{"id":1016,"date":"2026-05-25T03:50:16","date_gmt":"2026-05-25T03:50:16","guid":{"rendered":"https:\/\/wuhantopmiraclepeptides.com\/?post_type=product&#038;p=1016"},"modified":"2026-06-05T00:58:45","modified_gmt":"2026-06-05T00:58:45","slug":"survotitude","status":"publish","type":"product","link":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/product\/survotitude\/","title":{"rendered":"Survotitude"},"content":{"rendered":"<h1><span class=\"\">Survotitude Research Peptide: Dual GCGR\/GLP-1R Agonist for Metabolic Studies<\/span><\/h1>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">In the evolving field of metabolic research, the development of multi-receptor agonists has opened new frontiers for studying obesity, type 2 diabetes, and metabolic dysfunction-associated steatohepatitis (MASH). At the forefront of this innovation is\u00a0<\/span><strong><span class=\"\">Survodutide research peptide<\/span><\/strong><span class=\"\">\u00a0(also known as BI 456906) \u2014 a novel 29\u2011amino\u2011acid, dual agonist of the glucagon receptor (GCGR) and the glucagon\u2011like peptide\u20111 receptor (GLP\u20111R)<\/span><span class=\"\">. By simultaneously targeting both of these key metabolic pathways, Survotitude offers a unique tool for investigating appetite regulation, energy homeostasis, and hepatic lipid metabolism<\/span><span class=\"\">.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">At Wuhan Top Miracle Peptides, we supply high-purity Survotitude<\/span><strong><span class=\"\">\u00a0research peptide<\/span><\/strong><span class=\"\">\u00a0to research institutions, laboratories, and wholesale buyers across the United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA. Every batch is synthesised with GMP\u2011compliant processes, HPLC\u2011verified to \u226599% purity, and accompanied by a Certificate of Analysis (COA) \u2014 ensuring your research is built on quality, reproducibility, and scientific integrity.<\/span><\/p>\n<h2><span class=\"\">What Makes Survotitude Research Peptide Unique?<\/span><\/h2>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Most metabolic research peptides target a single receptor pathway.\u00a0<\/span><strong><span class=\"\">Survodutide research peptide<\/span><\/strong><span class=\"\">\u00a0is different. It is engineered as a dual agonist with a balanced, potent activation of both GCGR and GLP\u20111R (EC\u2085\u2080 = 0.52\u202fnM and 0.33\u202fnM, respectively, in CHO\u2011K1 cells)<\/span><span class=\"\">. This dual mechanism produces complementary effects:<\/span><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">GLP\u20111R activation<\/span><\/strong><span class=\"\">\u00a0\u2013 Reduces appetite, delays gastric emptying, and improves blood sugar control via central satiety signalling.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">GCGR activation<\/span><\/strong><span class=\"\">\u00a0\u2013 Increases energy expenditure, promotes fatty acid oxidation, and reduces hepatic fat accumulation through peripheral and central pathways.<\/span><\/p>\n<\/li>\n<\/ul>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">A recent 2026 study published in\u00a0<\/span><em><span class=\"\">Molecular Metabolism<\/span><\/em><span class=\"\"> demonstrated that Survotitude acts through circumventricular organs (CVOs) in the brain, directly accessing satiety\u2011mediating nuclei without uniformly crossing the blood\u2011brain barrier<\/span><span class=\"\">. This targeted central action suppresses food intake via GLP\u20111R\u2011dependent pathways, while GCGR\u2011driven mechanisms enhance energy expenditure \u2014 a true dual mode of action for studying complex metabolic phenotypes<\/span><span class=\"\">.<\/span><\/p>\n<h2><span class=\"\">Chemical &amp; Physical Specifications<\/span><\/h2>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Understanding the molecular characteristics of Survotitude <\/span><strong><span class=\"\">research peptide<\/span><\/strong><span class=\"\">\u00a0is essential for reproducible experimental design. Below are the verified specifications.<\/span><\/p>\n<div class=\"ds-scroll-area ds-scroll-area--show-on-focus-within ds-scroll-area--enabled _1210dd7 c03cafe9\">\n<div class=\"ds-scroll-area__gutters\">\n<div class=\"ds-scroll-area__horizontal-gutter\"><\/div>\n<div class=\"ds-scroll-area__vertical-gutter\"><\/div>\n<\/div>\n<table>\n<thead>\n<tr>\n<th><span class=\"\">Parameter<\/span><\/th>\n<th><span class=\"\">Specification<\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong><span class=\"\">Sequence (abbreviated)<\/span><\/strong><\/td>\n<td><span class=\"\">His-{1-Aminocyclobutanecarboxylic acid}-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Glu-Arg-Ala-Ala-Lys-Asp-Phe-Ile-{Lys(Gly-Ser-Gly-Ser-Gly-Gly-\u03b3Glu-C18 diacid)}-Trp-Leu-Glu-Ser-Ala-NH\u2082<\/span><\/td>\n<\/tr>\n<tr>\n<td><strong><span class=\"\">Molecular Formula<\/span><\/strong><\/td>\n<td><span class=\"\">C\u2081\u2089\u2082H\u2082\u2088\u2089N\u2084\u2087O\u2086\u2081<\/span><\/td>\n<\/tr>\n<tr>\n<td><strong><span class=\"\">Molecular Weight (free base)<\/span><\/strong><\/td>\n<td><span class=\"\">4231.62 g\/mol<\/span><\/td>\n<\/tr>\n<tr>\n<td><strong><span class=\"\">CAS Number<\/span><\/strong><\/td>\n<td><span class=\"\">2805997\u201146\u20118<\/span><\/td>\n<\/tr>\n<tr>\n<td><strong><span class=\"\">Purity<\/span><\/strong><\/td>\n<td><span class=\"\">\u226599% (HPLC verified)<\/span><\/td>\n<\/tr>\n<tr>\n<td><strong><span class=\"\">Appearance<\/span><\/strong><\/td>\n<td><span class=\"\">White to off\u2011white lyophilised powder<\/span><\/td>\n<\/tr>\n<tr>\n<td><strong><span class=\"\">Reconstitution<\/span><\/strong><\/td>\n<td><span class=\"\">Sterile bacteriostatic water or sterile PBS, pH 5\u20137<\/span><\/td>\n<\/tr>\n<tr>\n<td><strong><span class=\"\">Storage (Lyophilised)<\/span><\/strong><\/td>\n<td><span class=\"\">\u201320\u00b0C, sealed, protected from light; stable for up to 2 years<\/span><\/td>\n<\/tr>\n<tr>\n<td><strong><span class=\"\">Storage (Reconstituted)<\/span><\/strong><\/td>\n<td><span class=\"\">2\u20138\u00b0C, use within 28 days; single\u2011use aliquots at \u201320\u00b0C for up to 3 months<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">The sequence includes a non\u2011coded amino acid (1\u2011aminocyclobutane\u20111\u2011carboxylic acid) at position\u202f2 to enhance proteolytic stability, and a C18 fatty diacid moiety conjugated via a glycine\u2011serine linker to extend half\u2011life through albumin binding<\/span><span class=\"\">.<\/span><\/p>\n<blockquote>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">A note on spelling:<\/span><\/strong><span class=\"\">\u00a0The research community widely recognises this peptide as\u00a0<\/span><strong><span class=\"\">Survodutide<\/span><\/strong><span class=\"\">\u00a0(with a &#8220;d&#8221;). Some online sources may use the misspelling &#8220;Survotitude&#8221;. The correct chemical name and CAS number are confirmed by the manufacturer and independent suppliers<\/span><span class=\"\">.<\/span><\/p>\n<\/blockquote>\n<h2><span class=\"\">Key Research Applications for Survodutide Research Peptide<\/span><\/h2>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Survodutide research peptide<\/span><\/strong><span class=\"\">\u00a0has been extensively investigated across multiple areas of metabolic disease research.<\/span><\/p>\n<h3><span class=\"\">\u00a0Obesity &amp; Appetite Regulation Research<\/span><\/h3>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Survotitude has demonstrated robust, dose\u2011dependent weight loss in preclinical and clinical models. In the Phase\u202f3 SYNCHRONIZE\u20111 trial (NCT06066515), 725 adults with obesity or overweight were treated with weekly subcutaneous Survodutide (3.6\u202fmg or 6.0\u202fmg) for 76 weeks. Results showed mean body weight reductions of <\/span><strong><span class=\"\">16.6%<\/span><\/strong><span class=\"\">\u00a0versus 3.2% with placebo<\/span><span class=\"\">. Up to\u00a0<\/span><strong><span class=\"\">85.1%<\/span><\/strong><span class=\"\">\u00a0of treated participants achieved \u22655% weight loss, compared to 38.8% in the placebo arm<\/span><span class=\"\">.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Preclinical mechanistic studies have shown that Survodutide&#8217;s intake\u2011suppressive effects are GLP\u20111R\u2011dependent, activating c\u2011Fos in multiple satiety\u2011mediating nuclei<\/span><span class=\"\">. The GCGR component complements this by driving energy expenditure, making Survotitude a valuable tool for studying the interplay between appetite and metabolism.<\/span><\/p>\n<h3><span class=\"\">\u00a0Metabolic Dysfunction\u2011Associated Steatohepatitis (MASH) &amp; Hepatic Research<\/span><\/h3>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Survodutide&#8217;s glucagon co\u2011agonism directly targets hepatic fat oxidation and fibrosis pathways. A Phase\u202f2 trial in MASH patients with liver fibrosis (stages\u202f2\u20133) reported:<\/span><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">\u226565% reduction<\/span><\/strong><span class=\"\">\u00a0in liver fat content (MRI\u2011measured) in the 4.8\u202fmg dose group<\/span><span class=\"\">.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">63\u201367%<\/span><\/strong><span class=\"\">\u00a0of participants achieved a \u226530% reduction in liver fat<\/span><span class=\"\">.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">34\u201336%<\/span><\/strong><span class=\"\">\u00a0showed improvement in fibrosis by at least one stage<\/span><span class=\"\">.<\/span><\/p>\n<\/li>\n<\/ul>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">These findings highlight Survodutide&#8217;s potential as a research tool for studying hepatic lipid metabolism, fibrosis regression, and the pathophysiology of MASH.<\/span><\/p>\n<h3><span class=\"\">\u00a0Lean Mass Preservation &amp; Body Composition<\/span><\/h3>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Unlike single\u2011agonist GLP\u20111R peptides, Survodutide&#8217;s GCGR activation may favour\u00a0<\/span><strong><span class=\"\">fat\u2011specific weight loss<\/span><\/strong><span class=\"\"> while sparing lean mass. In preclinical models, lean mass loss was not significantly different between Survotitude and semaglutide treatment (8.3\u202f\u00b1\u202f0.8% vs. 5.3\u202f\u00b1\u202f0.9%, p\u202f=\u202f0.9071), indicating that weight reduction was driven primarily by fat loss, not muscle catabolism<\/span><span class=\"\">. This mechanistic distinction is critical for research into sarcopenic obesity and metabolic health.<\/span><\/p>\n<h3><span class=\"\">\u00a0Energy Expenditure &amp; Fatty Acid Oxidation<\/span><\/h3>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">An ongoing Phase\u202f2 trial (NCT06745284) is specifically examining how Survodutide alters energy expenditure and fatty acid oxidation in participants with obesity. The study uses whole\u2011body calorimetry to measure oxygen consumption and carbon dioxide production, providing direct insights into the metabolic impact of GCGR activation<\/span><span class=\"\">.<\/span><\/p>\n<h3><span class=\"\">\u00a0Type 2 Diabetes Research<\/span><\/h3>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Survodutide has demonstrated clinically meaningful blood sugar lowering in Phase\u202f2 trials, with efficacy comparable to or exceeding that of selective GLP\u20111R agonists. The dual mechanism improves both glucose\u2011dependent insulin secretion and insulin sensitivity, offering a comprehensive model for studying diabetic pathophysiology and therapeutic strategies<\/span><span class=\"\">.<\/span><\/p>\n<h2><span class=\"\">Survodutide vs. Other Peptide Agonists: A Research Comparison<\/span><\/h2>\n<div class=\"ds-scroll-area ds-scroll-area--show-on-focus-within ds-scroll-area--enabled _1210dd7 c03cafe9\">\n<div class=\"ds-scroll-area__gutters\">\n<div class=\"ds-scroll-area__horizontal-gutter\">\n<div class=\"ds-scroll-area__horizontal-bar\"><\/div>\n<\/div>\n<div class=\"ds-scroll-area__vertical-gutter\"><\/div>\n<\/div>\n<table>\n<thead>\n<tr>\n<th><span class=\"\">Feature<\/span><\/th>\n<th><span class=\"\">Survodutide (BI 456906)<\/span><\/th>\n<th><span class=\"\">Semaglutide<\/span><\/th>\n<th><span class=\"\">Tirzepatide<\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><strong><span class=\"\">Receptor targets<\/span><\/strong><\/td>\n<td><span class=\"\">GCGR &amp; GLP\u20111R (dual)<\/span><\/td>\n<td><span class=\"\">GLP\u20111R (selective)<\/span><\/td>\n<td><span class=\"\">GLP\u20111R &amp; GIPR (dual)<\/span><\/td>\n<\/tr>\n<tr>\n<td><strong><span class=\"\">Primary metabolic effect<\/span><\/strong><\/td>\n<td><span class=\"\">Appetite suppression + increased energy expenditure<\/span><\/td>\n<td><span class=\"\">Appetite suppression<\/span><\/td>\n<td><span class=\"\">Appetite suppression<\/span><\/td>\n<\/tr>\n<tr>\n<td><strong><span class=\"\">Hepatic fat reduction<\/span><\/strong><\/td>\n<td><span class=\"\">Yes (direct glucagon pathway)<\/span><\/td>\n<td><span class=\"\">Indirect via weight loss<\/span><\/td>\n<td><span class=\"\">Indirect via weight loss<\/span><\/td>\n<\/tr>\n<tr>\n<td><strong><span class=\"\">Lean mass preservation signal<\/span><\/strong><\/td>\n<td><span class=\"\">Favourable (preclinical)<\/span><\/td>\n<td><span class=\"\">Unknown<\/span><\/td>\n<td><span class=\"\">Unknown<\/span><\/td>\n<\/tr>\n<tr>\n<td><strong><span class=\"\">Key research niche<\/span><\/strong><\/td>\n<td><span class=\"\">Combined obesity + MASH models<\/span><\/td>\n<td><span class=\"\">Selective GLP\u20111R models<\/span><\/td>\n<td><span class=\"\">GIP\u2011mediated models<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">For researchers, Survodutide offers a distinct advantage: the ability to study\u00a0<\/span><strong><span class=\"\">both<\/span><\/strong><span class=\"\">\u00a0central appetite control (via GLP\u20111R) and peripheral energy metabolism (via GCGR) within a single molecular platform.<\/span><\/p>\n<h2><span class=\"\">Reconstitution &amp; Handling Protocol<\/span><\/h2>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Survodutide research peptide<\/span><\/strong><span class=\"\">\u00a0is supplied as a lyophilised powder and must be reconstituted correctly to maintain its stability and biological activity.<\/span><\/p>\n<h3><span class=\"\">Step 1 \u2013 Preparation<\/span><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Bring the sealed Survodutide vial and your chosen diluent (sterile bacteriostatic water or sterile PBS, pH\u202f5\u20137) to room temperature before opening.\u00a0<\/span><em><span class=\"\">Condensation can degrade the lyophilised powder.<\/span><\/em><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Clean your work surface with 70% ethanol and prepare sterile syringes, alcohol wipes, and a clean work mat.<\/span><\/p>\n<\/li>\n<\/ul>\n<h3><span class=\"\">Step 2 \u2013 Vial Sanitisation<\/span><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Wipe the rubber stoppers of both the Survodutide vial and the diluent vial with a fresh alcohol wipe. Allow the alcohol to evaporate completely before piercing.<\/span><\/p>\n<\/li>\n<\/ul>\n<h3><span class=\"\">Step 3 \u2013 Reconstitution<\/span><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Draw your desired volume of diluent into a sterile syringe (e.g., 1\u202fmL for a 5\u202fmg vial \u2192 5\u202fmg\/mL concentration).<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Insert the needle and slowly inject the diluent\u00a0<\/span><strong><span class=\"\">against the inner glass wall<\/span><\/strong><span class=\"\">. Do not spray directly onto the lyophilised powder.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Gently swirl the vial until the solution is clear and fully dissolved. Do not shake vigorously.<\/span><\/p>\n<\/li>\n<\/ul>\n<h3><span class=\"\">Step 4 \u2013 Aliquoting &amp; Storage<\/span><\/h3>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Immediately aliquot the reconstituted peptide into single\u2011use sterile vials.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Store aliquots at \u201320\u00b0C. Avoid repeated freeze\u2011thaw cycles.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Once thawed, store at 2\u20138\u00b0C and use within 28 days.<\/span><\/p>\n<\/li>\n<\/ul>\n<h3><span class=\"\">Concentration Reference Table<\/span><\/h3>\n<div class=\"ds-scroll-area ds-scroll-area--show-on-focus-within ds-scroll-area--enabled _1210dd7 c03cafe9\">\n<div class=\"ds-scroll-area__gutters\">\n<div class=\"ds-scroll-area__horizontal-gutter\"><\/div>\n<div class=\"ds-scroll-area__vertical-gutter\"><\/div>\n<\/div>\n<table>\n<thead>\n<tr>\n<th><span class=\"\">Vial Mass<\/span><\/th>\n<th><span class=\"\">Diluent Volume<\/span><\/th>\n<th><span class=\"\">Final Concentration<\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span class=\"\">5 mg<\/span><\/td>\n<td><span class=\"\">1 mL<\/span><\/td>\n<td><span class=\"\">5 mg\/mL<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">10 mg<\/span><\/td>\n<td><span class=\"\">2 mL<\/span><\/td>\n<td><span class=\"\">5 mg\/mL<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">25 mg<\/span><\/td>\n<td><span class=\"\">5 mL<\/span><\/td>\n<td><span class=\"\">5 mg\/mL<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">50 mg<\/span><\/td>\n<td><span class=\"\">10 mL<\/span><\/td>\n<td><span class=\"\">5 mg\/mL<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p class=\"ds-markdown-paragraph\"><em><span class=\"\">Adjust diluent volume proportionally based on your experimental requirements.<\/span><\/em><\/p>\n<h2><span class=\"\">Storage &amp; Stability Guidelines<\/span><\/h2>\n<div class=\"ds-scroll-area ds-scroll-area--show-on-focus-within ds-scroll-area--enabled _1210dd7 c03cafe9\">\n<div class=\"ds-scroll-area__gutters\">\n<div class=\"ds-scroll-area__horizontal-gutter\"><\/div>\n<div class=\"ds-scroll-area__vertical-gutter\"><\/div>\n<\/div>\n<table>\n<thead>\n<tr>\n<th><span class=\"\">Condition<\/span><\/th>\n<th><span class=\"\">Shelf Life<\/span><\/th>\n<th><span class=\"\">Notes<\/span><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><span class=\"\">Lyophilised at \u201320\u00b0C<\/span><\/td>\n<td><span class=\"\">2 years<\/span><\/td>\n<td><span class=\"\">Use desiccant, protect from light<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Lyophilised at 2\u20138\u00b0C<\/span><\/td>\n<td><span class=\"\">6\u201312 months<\/span><\/td>\n<td><span class=\"\">Acceptable short\u2011term storage<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Reconstituted at 2\u20138\u00b0C<\/span><\/td>\n<td><span class=\"\">28 days<\/span><\/td>\n<td><span class=\"\">Use aseptic technique<\/span><\/td>\n<\/tr>\n<tr>\n<td><span class=\"\">Reconstituted aliquots at \u201320\u00b0C<\/span><\/td>\n<td><span class=\"\">3 months<\/span><\/td>\n<td><span class=\"\">Single freeze only; do not refreeze<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<h2><span class=\"\">Quality Assurance &amp; Why Choose Wuhan Top Miracle Peptides<\/span><\/h2>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">As a licensed peptide supplier in the United Kingdom, we supply\u00a0<\/span><strong><span class=\"\">Survodutide research peptide<\/span><\/strong><span class=\"\">\u00a0with uncompromising quality standards.<\/span><\/p>\n<ul>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">\u226599% purity<\/span><\/strong><span class=\"\">\u00a0confirmed by HPLC and mass spectrometry for every batch.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">GMP\u2011compliant manufacturing<\/span><\/strong><span class=\"\">\u00a0in ISO\u202f13485:2016 and GMP\u2011certified facilities.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Full traceability<\/span><\/strong><span class=\"\">\u00a0with batch\u2011specific Certificates of Analysis (COA).<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Wholesale pricing<\/span><\/strong><span class=\"\">\u00a0\u2013 from single vials to bulk orders for research institutions.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Fast domestic shipping<\/span><\/strong><span class=\"\">\u00a0across the UK (London, Manchester, Birmingham, Edinburgh, etc.) and reliable delivery to the EU and USA.<\/span><\/p>\n<\/li>\n<li>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Research\u2011use only (RUO)<\/span><\/strong><span class=\"\">\u00a0\u2013 fully compliant with UK, EU, and international regulations.<\/span><\/p>\n<\/li>\n<\/ul>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">Researchers across the United Kingdom trust us for verified purity, transparent documentation, and technical support.<\/span><\/p>\n<h2><span class=\"\">FAQ: Survotitude Research Peptide<\/span><\/h2>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">\u00a0What is Survodutide research peptide?<\/span><\/strong><br \/>\n<span class=\"\">Survodutide (BI\u202f456906) is a 29\u2011amino\u2011acid, dual agonist of the glucagon receptor (GCGR) and GLP\u20111 receptor (GLP\u20111R). It is used in metabolic research to study obesity, MASH, type\u202f2 diabetes, and energy homeostasis.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">\u00a0What is the molecular weight of Survodutide?<\/span><\/strong><br \/>\n<span class=\"\">The molecular weight of the free base is approximately 4,231.62\u202fg\/mol. The acylated C18 diacid moiety and linker contribute to its extended half\u2011life.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">\u00a0How does Survodutide differ from semaglutide or tirzepatide for research?<\/span><\/strong><br \/>\n<span class=\"\">Survodutide activates both GCGR and GLP\u20111R. This dual mechanism allows researchers to study\u00a0<\/span><strong><span class=\"\">both appetite suppression (GLP\u20111R)<\/span><\/strong><span class=\"\">\u00a0and\u00a0<\/span><strong><span class=\"\">increased energy expenditure \/ hepatic fat oxidation (GCGR)<\/span><\/strong><span class=\"\">\u00a0within a single compound \u2014 features not present in selective GLP\u20111R agonists.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">\u00a0Is Survodutide the same as &#8220;Survotitude&#8221;?<\/span><\/strong><br \/>\n<span class=\"\">Yes, &#8220;Survotitude&#8221; is a common misspelling. The correct chemical name and CAS number (2805997\u201146\u20118) refer to Survodutide. All reputable suppliers and the published literature use\u00a0<\/span><strong><span class=\"\">Survodutide<\/span><\/strong><span class=\"\">.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">\u00a0What purity does your Survodutide meet?<\/span><\/strong><br \/>\n<span class=\"\">Our Survodutide research peptide is tested to \u226599% purity by HPLC. Each batch is accompanied by a COA with full analytical data.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">\u00a0How should I reconstitute Survodutide?<\/span><\/strong><br \/>\n<span class=\"\">Use sterile bacteriostatic water or sterile PBS (pH\u202f5\u20137). Bring the vial to room temperature, inject the diluent slowly against the inner glass wall, then swirl gently. Do not shake.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">\u00a0Is Survodutide legal to purchase in the UK for research?<\/span><\/strong><br \/>\n<span class=\"\">Yes. Survotitude is a laboratory reagent sold for research use only (RUO). It is fully legal to purchase, possess, and use in the UK for legitimate in\u2011vitro or in\u2011vivo scientific research, provided it is not marketed with therapeutic claims.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">\u00a0Do you ship Survodutide to France, Germany, Spain, Sweden, Italy, or the USA?<\/span><\/strong><br \/>\n<span class=\"\">Absolutely. We ship across the EU and USA from our UK warehouse. Wholesale pricing is available for bulk orders.<\/span><\/p>\n<h2 data-section-id=\"1rqn06o\" data-start=\"6657\" data-end=\"6703\">Documentation, COA, and Quality Information<\/h2>\n<p data-start=\"6705\" data-end=\"6838\">Professional buyers may request available documentation before discussing supply. This section should link directly to your COA page.<\/p>\n<h3 data-section-id=\"brqnwl\" data-start=\"6840\" data-end=\"6869\">Suggested Quality Message<\/h3>\n<p data-start=\"6871\" data-end=\"7179\">At Wuhan Top Miracle Peptides, verified buyers may contact our team to request available documentation, batch information, COA details, purity-related information, storage notes, and supply requirements for Survotitude. Documentation availability may vary by product, batch, country, and buyer qualification.<\/p>\n<ul data-start=\"7210\" data-end=\"7496\">\n<li data-section-id=\"z7abbw\" data-start=\"7279\" data-end=\"7309\"><a href=\"https:\/\/wuhantopmiraclepeptides.com\/index.php\/about-us\/\">Product label verification<\/a><\/li>\n<li data-section-id=\"1201p1m\" data-start=\"7310\" data-end=\"7366\"><a href=\"https:\/\/wuhantopmiraclepeptides.com\/index.php\/about-us\/\">Storage and handling notes where legally appropriate<\/a><\/li>\n<li data-section-id=\"zod00c\" data-start=\"7403\" data-end=\"7431\"><a href=\"https:\/\/wuhantopmiraclepeptides.com\/index.php\/contact-us\/\">Business contact details<\/a><\/li>\n<li data-section-id=\"1c72i4t\" data-start=\"7465\" data-end=\"7496\"><a href=\"https:\/\/wuhantopmiraclepeptides.com\/index.php\/shipping-returns\/\">Shipping eligibility notice<\/a><\/li>\n<li data-section-id=\"lwbj22\" data-start=\"11402\" data-end=\"11503\"><strong data-start=\"11405\" data-end=\"11448\">Reuters Survotitude Phase III reporting<\/strong><br data-start=\"11448\" data-end=\"11451\" \/><strong data-start=\"11508\" data-end=\"11533\">Google Search Central<\/strong><br data-start=\"11533\" data-end=\"11536\" \/><strong data-start=\"11592\" data-end=\"11630\">MHRA medicine advertising guidance<\/strong><br data-start=\"11630\" data-end=\"11633\" \/><strong data-start=\"11685\" data-end=\"11742\">ASA\/CAP medicine and health product advertising rules<\/strong><\/li>\n<\/ul>\n<h2 data-section-id=\"uyt3g6\" data-start=\"7503\" data-end=\"7533\">Professional Supply Regions For Survotitude<\/h2>\n<p data-start=\"7535\" data-end=\"7640\">Wuhan Top Miracle Peptides supports wholesale and professional product enquiries across multiple regions.<\/p>\n<h3 data-section-id=\"1ihzbnk\" data-start=\"7642\" data-end=\"7661\">Enquiry Regions<\/h3>\n<ul data-start=\"7663\" data-end=\"7760\">\n<li data-section-id=\"1anqy5e\" data-start=\"7663\" data-end=\"7681\">United Kingdom<\/li>\n<li data-section-id=\"w5ual1\" data-start=\"7682\" data-end=\"7692\">France<\/li>\n<li data-section-id=\"1d9bbc3\" data-start=\"7693\" data-end=\"7704\">Germany<\/li>\n<li data-section-id=\"1mveevh\" data-start=\"7705\" data-end=\"7714\">Spain<\/li>\n<li data-section-id=\"1abyjq\" data-start=\"7715\" data-end=\"7725\">Sweden<\/li>\n<li data-section-id=\"zt94rl\" data-start=\"7726\" data-end=\"7735\">Italy<\/li>\n<li data-section-id=\"17bvhhr\" data-start=\"7736\" data-end=\"7743\">USA<\/li>\n<li data-section-id=\"2seaf1\" data-start=\"7744\" data-end=\"7760\">Wider Europe<\/li>\n<\/ul>\n<p data-start=\"7762\" data-end=\"7892\">Survotitude<\/p>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">From appetite regulation and energy expenditure to hepatic lipid oxidation and lean mass preservation,\u00a0<\/span><strong><span class=\"\">Survodutide research peptide<\/span><\/strong><span class=\"\">\u00a0provides a well\u2011characterised, balanced dual agonist tool for advanced metabolic research. Its unique GLP\u20111R\/GCGR activation profile \u2014 supported by peer\u2011reviewed publications, clinical trial data, and a distinct advantage over single\u2011receptor compounds \u2014 makes it an essential addition to any laboratory studying obesity, MASH, or metabolic dysfunction.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><span class=\"\">By choosing high\u2011purity, lab\u2011verified\u00a0<\/span><strong><span class=\"\">Survodutide research peptide<\/span><\/strong><span class=\"\">\u00a0from Wuhan Top Miracle Peptides, you ensure that your research is built on a foundation of quality, reproducibility, and scientific integrity.<\/span><\/p>\n<p class=\"ds-markdown-paragraph\"><strong><span class=\"\">Ready to advance your metabolic research with Survodutide?<\/span><\/strong><span class=\"\">\u00a0Browse our product catalogue, request a wholesale quote, or contact our support team today to discuss your laboratory&#8217;s needs. Place your order now and receive laboratory\u2011ready, GMP\u2011quality Survodutide delivered directly to your facility in the UK, EU, or USA.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<h1>Survotitude<\/h1>\n<p>High-purity Survodutide research peptide for metabolic &amp; obesity studies. \u226599% purity. Trusted UK\/EU wholesale. Fast delivery.<\/p>\n","protected":false},"featured_media":390,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[18],"product_tag":[337,186,268,270,322,232,266,321,336,338,335,334,269,239],"class_list":["post-1016","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-bi-456906-peptide","product_tag-buy-survotitude","product_tag-coa-peptide-supplier-uk","product_tag-europe-peptide-wholesale-supplier","product_tag-glp-1-glucagon-dual-agonist","product_tag-peptide-purity-uk","product_tag-professional-peptide-supplier-uk","product_tag-research-peptide-supplier-uk","product_tag-survodutide-peptide-uk","product_tag-survodutide-professional-enquiry","product_tag-survodutide-uk","product_tag-survotitude-peptide","product_tag-uk-peptide-supplier","product_tag-wholesale-peptides-uk","first","instock","shipping-taxable","purchasable","product-type-simple"],"_links":{"self":[{"href":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/wp-json\/wp\/v2\/product\/1016","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/wp-json\/wp\/v2\/comments?post=1016"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/wp-json\/wp\/v2\/media\/390"}],"wp:attachment":[{"href":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/wp-json\/wp\/v2\/media?parent=1016"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/wp-json\/wp\/v2\/product_brand?post=1016"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/wp-json\/wp\/v2\/product_cat?post=1016"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/wp-json\/wp\/v2\/product_tag?post=1016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}